Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy

Yu Hung Huang, Weidan Peng, Narumi Furuuchi, James B. DuHadaway, Masaya Jimbo, Andrea Pirritano, Charles J. Dunton, Gary S. Daum, Benjamin E. Leiby, Jonathan R. Brody, Janet A. Sawicki

Research output: Contribution to journal › Article › peer-review